NewsSource: EClinCloud

EClinCloud Product Overview | eCOA: Electronic Clinical Outcome Assessment System

2 min readEClinCloud Editorial Team
Article illustration

Source: EClinCloud. Author: EClinCloud.

Article illustration



EClinCloud eCOA (electronic Clinical Outcome Assessment) is the digital version of clinical outcome assessment (COA). Integrating mobile and PC platforms, it collects comprehensive trial data across five dimensions: ePRO (electronic patient-reported outcome), eClinRO (electronic clinician-reported outcome), eObsRO (electronic observer-reported outcome), ePerfO (electronic performance outcome), and eDiary (electronic diary).


eCOA

One-Stop Product + Service Solution





1

What EClinCloud Provides

1

Scale management and consulting

2

Rater training

3

Electronic study system build

4

System training and quality control


2

Features of the EClinCloud eCOA System

1

Alert rules and multidimensional two-way reminders help users carry out proactive data quality control

2

Proprietary trained AI models assist users in implementing unified SOP standards

3

Provides full-workflow functional operations for data quality management, meeting the necessary conditions for operating in data silos

4

Comprehensive task menu enabling users to view task counts, details, and processing progress in real time



3

Why Choose EClinCloud eCOA?

Article illustration

Clean and efficient system with comprehensive functional support and no extra reporting burden

Complete and robust closed-loop data workflow

Dedicated project software and hardware solution team with full-lifecycle service tracking

Reusable experience from successful inspections across multi-indication studies






About EClinCloud

EClinCloud is a technology company focused on clinical R&D. It provides an integrated, interoperable, all-in-one clinical trial cloud platform (including different technology products such as eCOA, CTMS, eTMF, EDC, RTSM, and RM, as well as solutions within its offerings such as scale design, scale copyright management, linguistic validation, rater training, and data quality analysis) along with clinical trial endpoint assessment technologies across therapeutic areas (including central nervous system, ophthalmology, and others). By combining cutting-edge technology with life data, EClinCloud is building a globally leading, "patient-centered" clinical evidence support SaaS cloud platform to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.







Article illustration

Read original WeChat article

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.